Etomidate

Question 1

Etomidate

Classification -

1. _(list of three)_

Answer 1

Etomidate

Classification -

1. Non-narcotic, non-barbiturate, sedative hypnotic.

Question 2

Etomidate

Action -

1. ___

Answer 2

Etomidate

Action -

1. Depresses the activity of the brain stem reticular system. It may lower intraocular and intracranial pressure, and lower the rate of cerebral oxygen utilization, all with minimal cardiovascular and respiratory depressant effects.

Question 3

Etomidate

Onset of Action -

1. Within 10-60 seconds.

Answer 3

Etomidate

Onset of Action -

1. Within 10-60 seconds.

Question 4

Etomidate

Duration of Action -

1. ___

Answer 4

Etomidate

Duration of Action -

1. Dose dependent but can be 3-5 minutes with full recovery in 15 minutes.

Question 5

Etomidate

Indication -

1. ___
2. ___

Answer 5

Etomidate

Indication -

1. Induction agent for RSI in adults and pediatric patients >= 10 years old.
2. Sedation prior to cardioversion.

Question 6

Etomidate

Contraindication -

1. ___
2. ___

Answer 6

Etomidate

Contraindication -

1. Known hypersensitivity to the agent.
2. Not recommended for pregnant or nursing mothers.

Question 7

Etomidate

Use with Caution -

1. ___

Answer 7

Etomidate

Use with Caution -

1. Elderly patients.

Question 8

Etomidate

Dosage and Administration -

1. Adult: Induction agent - ___ Sedation agent - ___

Answer 8

Etomidate

Dosage and Administration -

1. Adult: Induction agent - 0.3 mg/kg IV/IO push over 30-60 seconds. Sedation agent - 0.1 mg/kg IV/IO.

Question 9

Etomidate

Dosage and Administration -

Pediatric: ___

Answer 9

Etomidate

Dosage and Administration -

Pediatric: 0.3 mg/kg IV/IO push over 30-60 seconds. Max dose: 20 mg.

Question 10

Etomidate

Adverse Reaction

1. ___
2. ___
3. _(list of five)_

Answer 10

Etomidate

Adverse Reaction

1. Painful myoclonus (diffuse muscle contraction) which may be painful after patient awakens. This can be reduced by giving muscle relaxant immediately after Etomidate is given.
2. Pain at the injection site, moderated by using a large vessel and giving with IV fluid.
3. Apnea, Hypotension, Tachycardia, Nausea, Vomiting.